Personal tools
Log in
You are here: Home Education BOSS
The BOSS program inspires students and postdocs to explore exciting careers in industry.

BOSS Panel

 

 

The Biotechnology Opportunity Seminar Series (BOSS) inspires students and postdocs to explore exciting careers in industry. Leaders in the biotech industry are invited to talk about their company, their work and their career experiences. These speakers bring insight and networking opportunities to researchers who are interested in working outside of academia.

Bringing companies to campus:

BOSS began in 2010 as a partnership with the CU Biotech Club and the Deming Center for Entrepreneurship. Since then, BOSS has sponsored 21 seminars featuring industry leaders. BOSS has hosted John Milligan, President and Chief Operating Officer of Gilead Sciences and Thomas Harding, Senior Vice President of Preclinical Research and Translational Medicine at Clovis Oncology. These seminars have been made possible with the support of Jim and Patience Linfield and Cooley LLP.

Recent Seminars:

  • Mark Muller, Founder and CEO of TopoGEN - "Cell Based Reporters for Epigenetic Revisions and Pathway Discovery in Cancer, Potential Collaborations and Career Opportunities for Biotech Startups"
  • John Milligan, President and Chief Operating Officer of Gilead Sciences - "Gilead Sciences: A Perspective on Ensuring Access to Medicines in the Developing World"
  • Tom Harding, Sr. Vice President of Preclinical Research and Translational Medicine at Clovis Oncology - "Cancer research at Clovis Oncology: Active areas, possible collaborations and career opportunities in industry"
  • Larry Gold, Chairman and Founder of Somologic - "The Proteomics Explosion"

 

BioFrontiers has a goal of developing new technologies in partnership with industry, and typically brings in speakers with research interests that overlap with the research being done at the institute. If you are a member of a student-led group interested in developing a hosting an event with the BOSS program, please contact Jana Watson-Capps for more information.